GC Biopharma’s “GC FLU” obtains vaccine approval in Egypt: First-ever approval of the company’s quadrivalent flu vaccine on the African continent

GC Biopharma, a South Korean biopharmaceutical company, announced on the 18th that its quadrivalent flu vaccine called GC FLU Quadrivalent Pre-filled syringe inj.

Scroll to Top